UBS Maintains Neutral on Qiagen, Lowers Price Target to $36

UBS maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $39 to $36.

Benzinga · 01/10/2020 15:43

UBS maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $39 to $36.